Mesenchymal Stem Cells as a Treatment for Peripheral Arterial Disease: Current Status and Potential Impact of Type II Diabetes on Their Therapeutic Efficacy

Stem Cell Reviews and Reports

Volumn 9, Issue 3, 2013, Pages 360-372

  Yan, Jinglian ^a   Tie, Guodong ^a   Xu, Ting Yu ^a   Cecchini, Katharine ^a   Messina, Louis M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Limb ischemia; Mesenchymal stem cells; Oxidative stress; Peripheral arterial disease

Indexed keywords

ANGIOGENESIS; ANIMAL; BIOLOGICAL THERAPY; CELL TRANSDIFFERENTIATION; HINDLIMB; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; VASCULARIZATION;

ANIMALS; CELL TRANSDIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; DIABETES MELLITUS, TYPE 2; HINDLIMB; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; PERIPHERAL ARTERIAL DISEASE;

MUS;

EID: 84878957376     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-013-9433-8     Document Type: Review

References (87)

1. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., et al. (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine, 5(4), 434-438.
2. Kinnaird, T., Stabile, E., Burnett, M. S., & Epstein, S. E. (2004). Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circulation Research, 95(4), 354-363.
3. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964-967.
4. Crosby, J. R., Kaminski, W., Schatteman, G., Martin, P. J., Raines, E. W., Seifert, R. A., et al. (2000). Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circulation Research, 87(9), 728-730.
5. Sneider, E. B., Nowicki, P., & Messina, L. M. (2009). Regenerative medicine in the treatment of peripheral arterial disease. Journal of Cellular Biochemistry, 108(4), 753-761.
6. Pittenger, M. F., Mackay, A., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143-147.
7. Bianco, P., & Gehron Robey, P. (2000). Marrow stromal stem cells. The Journal of Clinical Investigation, 105(12), 1663-1668.
8. Iwase, T., Nagaya, N., Fujii, T., Itoh, T., Murakami, S., Matsumoto, T., et al. (2005). Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovascular Research, 66(3), 543-551.
9. Lasala, G. P., Silva, J., & Minguell, J. J. (2012). Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product. The Journal of Thoracic and Cardiovascular Surgery, 144(2), 377-382.
10. Lawall, H., Bramlage, P., & Amann, B. (2010). Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thrombosis and Haemostasis, 103(4), 696-709.
11. Webber, M. J., Han, X., Murthy, S. N., Rajangam, K., Stupp, S. I., & Lomasney, J. W. (2010). Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases. Journal of Tissue Engineering and Regenerative Medicine, 4(8), 600-610.
12. Lasala, G. P., & Minguell, J. (2011). Vascular disease and stem cell therapies. British Medical Bulletin, 98, 187-197.
13. de Nigris, F., Balestrieri, M., Williams-Ignarro, S., D'Armiento, F. P., Lerman, L. O., Byrns, R., et al. (2007). Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. Journal of Cardiovascular Pharmacology, 50(4), 424-433.
14. Kang, Y., Park, C., Kim, D., Seong, C. M., Kwon, K., & Choi, C. (2010). Unsorted human adipose tissue-derived stem cells promote angiogenesis and myogenesis in murine ischemic hindlimb model. Microvascular Research, 80(3), 310-316.
15. Chen, J., Li, Y., Wang, L., Lu, M., Zhang, X., & Chopp, M. (2001). Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. Journal of Neurological Sciences, 189(1-2), 49-57.
16. Jin, H. K., Carter, J., Huntley, G. W., & Schuchman, E. H. (2002). Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. The Journal of Clinical Investigation, 109(9), 1183-1191.
17. Dj, P. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276(5309), 71-74.
18. Ukai, R., Honmou, O., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2007). Mesenchymal stem cells derived from peripheral blood protects against ischemia. Journal of Neurotrauma, 24(3), 508-520.
19. Kim, S. W., Han, H., Chae, G. T., Lee, S. H., Bo, S., Yoon, J. H., et al. (2006). Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells, 24(6), 1620-1626.
20. Romanov, Y. A., Svintsitskaya, V., & Smirnov, V. N. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells, 21(1), 105-110.
21. Xu, Y., Meng, H., Li, C., Hao, M., Wang, Y., Yu, Z., et al. (2010). Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization. Stem Cells and Development, 19(10), 1511-1522.
22. Nakagami, H., Maeda, K., Morishita, R., Iguchi, S., Nishikawa, T., Takami, Y., et al. (2005). Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(12), 2542-2547.
23. Cho, H. H., Kim, Y., Kim, J. T., Song, J. S., Shin, K. K., Bae, Y. C., et al. (2009). The role of chemokines in proangiogenic action induced by human adipose tissue-derived mesenchymal stem cells in the murine model of hindlimb ischemia. Cellular Physiology and Biochemistry, 24(5-6), 511-518.
24. Iwashima, S., Ozaki, T., Maruyama, S., Saka, Y., Kobori, M., Omae, K., et al. (2009). Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue. Stem Cells and Development, 18(4), 533-543.
25. Fukuchi, Y., Nakajima, H., Sugiyama, D., Hirose, I., Kitamura, T., & Tsuji, K. (2004). Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells, 22(5), 649-658.
26. Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2011). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24(5), 1294-1301.
27. Bieback, K., Kern, S., Kocaömer, A., Ferlik, K., & Bugert, P. (2008). Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood. Biomedical Materials and Engineering, 18(1 Suppl), S71-S76.
28. Rebelatto, C. K., Aguilar, A., Moretão, M. P., Senegaglia, A. C., Hansen, P., Barchiki, F., et al. (2008). Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Experimental Biology and Medicine (Maywood, N. J.), 233(7), 901-913.
29. Gaebel, R., Furlani, D., Sorg, H., Polchow, B., Frank, J., Bieback, K., et al. (2011). Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One, 6(2), e15652.
30. Hoffmann, J., Glassford, A., Doyle, T. C., Robbins, R. C., Schrepfer, S., & Pelletier, M. P. (2010). Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia. Thoracic and Cardiovascular Surgeon, 58(3), 136-142.
31. Kim, Y., Kim, H., Cho, H., Bae, Y., Suh, K., & Jung, J. (2007). Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cellular Physiology and Biochemistry, 20(6), 867-876.
32. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861-872.
33. Yu, J., Vodyanik, M., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917-1920.
34. Lian, Q., Zhang, J., Zhang, H. K., Wu, X., Zhang, Y., Lam, F. F., et al. (2010). Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation, 121(9), 1113-1123.
35. Jung, Y., Bauer, G., & Nolta, J. A. (2012). Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells, 30(1), 42-47.
36. Gruenloh, W., Kambal, A., Sondergaard, C., McGee, J., Nacey, C., Kalomoiris, S., et al. (2011). Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Engineering. Part A, 17(11-12), 1517-1525.
37. Sánchez, L., Gutierrez-Aranda, I., Ligero, G., Rubio, R., Muñoz-López, M., García-Pérez, J. L., et al. (2011). Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells, 29(2), 251-262.
38. Laurila, J. P., Laatikainen, L., Castellone, M. D., Trivedi, P., Heikkila, J., Hinkkanen, A., et al. (2009). Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy, 11(6), 726-737.
39. Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., et al. (2005). Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy, 7(5), 393-395.
40. Reiser, J., Zhang, X., Hemenway, C. S., Mondal, D., Pradhan, L., & La Russa, V. F. (2005). Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opinion on Biological Therapy, 5(12), 1571-1584.
41. Wieczorek, G., Steinhoff, C., Schulz, R., Scheller, M., Vingron, M., Ropers, H. H., et al. (2003). Gene expression profile of mouse bone marrow stromal cells determined by cDNA microarray analysis. Cell and Tissue Research, 311(2), 227-237.
42. Camarillo, C., Swerdel, M., & Hart, R. P. (2011). Comparison of microarray and quantitative real-time PCR methods for measuring microRNA levels in MSC cultures. Methods in Molecular Biology, 698, 419-429.
43. Yan, J., Tie, G., Wang, S., Messina, K. E., DiDato, S., Guo, S., et al. (2012). Type 2 diabetes restricts mesenchymal stem cell multipotency and Impairs their capacity to augment post-ischemic neovascularization in db/db Mice. Journal of the American Heart Association, 1(e002238).
44. Hamou, C., Callaghan, M., Thangarajah, H., Chang, E., Chang, E. I., Grogan, R. H., et al. (2009). Mesenchymal stem cells can participate in ischemic neovascularization. Plastic and Reconstructive Surgery, 123(2 suppl), 45S-55S.
45. Li, M., Yu, J., Li, Y., Li, D., Yan, D., & Ruan, Q. (2010). CXCR4+ progenitors derived from bone mesenchymal stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Cellular Reprogramming, 12(4), 405-415.
46. Gong, Z., & Niklason, L. (2011). Use of human mesenchymal stem cells as alternative source of smooth muscle cells in vessel engineering. Methods in Molecular Biology, 698, 279-294.
47. Toma, C., Pittenger, M., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105(1), 93-98.
48. Zhu, C. J., Dong, J., Li, J., Zhang, M. J., Wang, L. P., & Luo, L. (2011). Preliminary study on the mechanism of acupoint injection of bone marrow mesenchymal stem cells in improving blood flow in the rat of hind limb ischemia. Journal of Traditional Chinese Medicine, 31(3), 241-245.
49. Kinnaird, T., Stabile, E., Burnett, M. S., Shou, M., Lee, C. W., Barr, S., et al. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 109(12), 1543-1549.
50. Li, H., Zuo, S., He, Z., Yang, Y., Pasha, Z., Wang, Y., et al. (2010). Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival. American Journal of Physiology - Heart and Circulatory Physiology, 299(6), H1772-H1781.
51. Parekkadan, B., van Poll, D., Suganuma, K., Carter, E. A., Berthiaume, F., Tilles, A. W., et al. (2007). Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One, 2(9), e941.
52. Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., Hu, Q., Feigenbaum, G. S., Margitich, I. S., et al. (2010). Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circulation Research, 107(7), 913-922.
53. Liechty, K. W., MacKenzie, T., Shaaban, A. F., Radu, A., Moseley, A. M., Deans, R., et al. (2000). Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Medicine, 6(11), 1282-1286.
54. Stagg, J. (2007). Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens, 69(1), 1-9.
55. Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8(9), 726-736.
56. Shabbir, A., Zisa, D., Suzuki, G., & Lee, T. (2009). Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. American Journal of Physiology - Heart and Circulatory Physiology, 296(6), H1888-H1897.
57. Guiducci, S., Porta, F., Saccardi, R., Guidi, S., Ibba-Manneschi, L., Manetti, M., et al. (2010). Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report. Annals of Internal Medicine, 153(10), 650-654.
58. Schrepfer, S., Deuse, T., Reichenspurner, H., Fischbein, M. P., Robbins, R. C., & Pelletier, M. P. (2007). Stem cell transplantation: the lung barrier. Transplantation Proceedings, 39(2), 573-576.
59. Morikawa, S., Mabuchi, Y., Kubota, Y., Nagai, Y., Niibe, K., Hiratsu, E., et al. (2009). Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. The Journal of Experimental Medicine, 206(11), 2483-2496.
60. Ishii, M., Shibata, R., Numaguchi, Y., Kito, T., Suzuki, H., Shimizu, K., et al. (2011). Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(10), 2210-2215.
61. Wang, J., Cui, W., Ye, J., Ji, S., Zhao, X., Zhan, L., et al. (2012). A cellular delivery system fabricated with autologous BMSCs and collagen scaffold enhances angiogenesis and perfusion in ischemic hind limb. Journal of Biomedical Materials Research. Part A, 100(6), 1438-1447.
62. Cobellis, G., Silvestroni, A., Lillo, S., Sica, G., Botti, C., Maione, C., et al. (2008). Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease. Bone Marrow Transplantation, 42(10), 667-672.
63. Walter, D. H., Krankenberg, H., Balzer, J. O., Kalka, C., Baumgartner, I., Schlüter, M., et al. (2011). Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circulation. Cardiovascular Interventions, 4(1), 26-37.
64. Ruiz-Salmeron, R., de la Cuesta-Diaz, A., Constantino-Bermejo, M., Pérez-Camacho, I., Marcos-Sánchez, F., Hmadcha, A., et al. (2011). Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transplantation, 20(10), 1629-1639.
65. Zhang, Y., Zhang, R., Li, Y., He, G., Zhang, D., & Zhang, F. (2012). Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia. Molecular Biology Reports, 39(1), 285-293.
66. Jiang, C. Y., Gui, C., He, A. N., Hu, X. Y., Chen, J., Jiang, Y., et al. (2008). Optimal time for mesenchymal stem cell transplantation in rats with myocardial infarction. Journal of Zhejiang University. Science. B, 9(8), 630-637.
67. Jackson, K. A., Majka, S., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. The Journal of Clinical Investigation, 107(11), 1395-1402.
68. Zhang, G., Hu, Q., Braunlin, E. A., Suggs, L. J., & Zhang, J. (2008). Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Engineering. Part A, 14(6), 1025-1036.
69. Jeong, J. O., Han, J., Kim, J. M., Cho, H. J., Park, C., Lee, N., et al. (2011). Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circulation Research, 108(11), 1340-1347.
70. Miura, M., Miura, Y., Padilla-Nash, H. M., Molinolo, A. A., Fu, B., Patel, V., et al. (2006). Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells, 24(4), 1095-1103.
71. Hatzistergos, K. E., Blum, A., Ince, T., Grichnik, J. M., & Hare, J. M. (2011). What is the oncologic risk of stem cell treatment for heart disease? Circulation Research, 108(11), 1300-1303.
72. Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., et al. (2002). Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet, 360(9331), 427-435.
73. Miyamoto, M., Yasutake, M., Takano, H., Takagi, H., Takagi, G., Mizuno, H., et al. (2004). Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transplantation, 13(4), 429-437.
74. Mizuno, H., Miyamoto, M., Shimamoto, M., Koike, S., Hyakusoku, H., & Kuroyanagi, Y. (2010). Therapeutic angiogenesis by autologous bone marrow cell implantation together with allogeneic cultured dermal substitute for intractable ulcers in critical limb ischaemia. Journal of Plastic, Reconstructive & Aesthetic Surgery, 63(11), 1875-1882. Epub 2010 Jan.
75. Perin, E. C., Silva, G., Gahremanpour, A., Canales, J., Zheng, Y., Cabreira-Hansen, M. G., et al. (2011). A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia. Catheterization and Cardiovascular Interventions, 78(7), 1060-1067.
76. Lasala, G. P., Silva, J. A., Gardner, P. A., & Minguell, J. J. (2010). Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis. Angiology, 61(6), 551-556.
77. Lu, D., Chen, B., Liang, Z., Deng, W., Jiang, Y., Li, S., et al. (2011). Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Research and Clinical Practice, 92(1), 26-36.
78. Powell, R. J., Comerota, A. J., Berceli, S. A., Guzman, R., Henry, T. D., Tzeng, E., et al. (2011). Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia. Journal of Vascular Surgery, 54(4), 1032-1041.
79. Powell, R. J., Marston, W. A., Berceli, S. A., Guzman, R., Henry, T. D., Longcore, A. T., et al. (2012). Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial. Molecular Therapy, 20(6), 1280-1286.
80. Yan, J., Tie, G., Park, B., Yan, Y., Nowicki, P. T., & Messina, L. M. (2009). Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. Journal of Vascular Surgery, 50(6), 1412-1422.
81. Tie, G., Yan, J., Yang, Y., Park, B., & Messina, L. M. (2010). Oxidized low density lipoprotein inactivates PI3 kinase/Akt pathway in murine endothelial progenitor cell. Journal of Vascular Research, 47(6), 519-530.
82. Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D. H., et al. (2004). Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation, 109(13), 1615-1622.
83. Dimmeler, S., & Leri, A. (2008). Aging and disease as modifiers of efficacy of cell therapy. Circulation Research, 102(11), 1319-1330.
84. MacKenzie, T. C., & Flake, A. (2002). Human mesenchymal stem cells: insights from a surrogate in vivo assay system. Cells, Tissues, Organs, 171(1), 90-95.
85. Urbich, C., & Dimmeler, S. (2005). Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney International, 67(5), 1672-1676.
86. Amin, A. H., Abd Elmageed, Z., Nair, D., Partyka, M. I., Kadowitz, P. J., Belmadani, S., et al. (2010). Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice. Laboratory Investigation, 90(7), 985-996.
87. Dash, N. R., Dash, S. N., Routray, P., Mohapatra, S., & Mohapatra, P. C. (2009). Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Research, 12(5), 359-366.